ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma
BackgroundThe targeted therapy for lung cancer relies on feline 1-hcpch vaccine prognostic genes and requires further research.No research has been conducted to determine the effect of endothelin-converting enzyme 2 (ECE2) in lung cancer.MethodsWe analyzed the expression of ECE2 in lung adenocarcinoma (LUAD) and normal adjacent tissues and its rela